PRAME antigen presented on HLA-A*02:01

Assets acting on this target.

Class
HLA-restricted, autologous TCR-engineered T cell therapy (TCR-T)
Pathway
MHC class I-restricted antigen recognition driving T cell-mediated tumor cytotoxicity

Related mechanisms

← all mechanisms